As the popularity of prescription weight loss medications, including glucagon-like peptide-1 receptor agonists like Ozempic, continues to grow, the discussions around obesity care in the U.S. have started to shift.
As the popularity of prescription weight loss medications, including glucagon-like peptide-1 receptor agonists like Ozempic, continues to grow, the discussions around obesity care in the U.S. have started to shift.